Suchergebnisse - (Subject:"CD8-Positive T-Lymphocytes")

PubPharm (138)

1

The spatial landscape of T cells in the microenvironment of stage III lung adenocarcinoma

enthalten in: The Journal of pathology | 2024

von Zeng, Z. | Du, W. | Yang, F. | +7

2

RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment

enthalten in: Journal for immunotherapy of cancer | 2024

von Meng, Y. | Liu, H. | Zhu, H. | +5

ErratumIn: J Immunother Cancer. 2024 Jan 30;12(1):. - PMID 38290772

3

Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation

enthalten in: Journal for immunotherapy of cancer | 2024

von Ma, C. | Chen, P. | Du, J. | +7

4

Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer : Lin28a-based and Siglece-based vaccination induces antitumor immunity and inhibits metastasis

enthalten in: Journal for immunotherapy of cancer | 2023

von Carter, J. | Matta, B. | Battaglia, J. | +5

UpdateOf: bioRxiv. 2023 May 10;:. - PMID 37214884

5

Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion

enthalten in: Journal for immunotherapy of cancer | 2023

von Teagle, A. | Castro-Sanchez, P. | Brownlie, R. | +5

6

Targeting integrin α5 in fibroblasts potentiates colorectal cancer response to PD-L1 blockade by affecting extracellular-matrix deposition

enthalten in: Journal for immunotherapy of cancer | 2023

von Lu, L. | Gao, Y. | Huang, D. | +14

7

TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma

enthalten in: Journal for immunotherapy of cancer | 2023

von Yu, J. | Ling, S. | Hong, J. | +20

8

Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumors

enthalten in: Cytotherapy | 2023

von Choi, W. | Lee, Y. | Choi, B. | +9

9

Anti-CD19/CD8 bispecific T cell engager for the potential treatment of B cell malignancies

enthalten in: Cellular immunology | 2023

von Maghsoodi, N. | Zareinejad, M. | Golestan, A. | +2

10

PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma

enthalten in: Journal for immunotherapy of cancer | 2023

von Homicsko, K. | Zygoura, P. | Norkin, M. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]